GlaxoSmithKline has signed an agreement to acquire Nanjing MeiRui Pharma for US$70m, reported Pharmaceutical Business Review. MeiRui is a Chinese pharmaceutical business specialising in urology and allergy products. It has a manufacturing facility in Nanjing, capital of Jiangsu province.